Dede Willis

Dede Willis has a diverse work experience spanning several companies and industries. Dede is currently the CEO and CoFounder of Orbit Genomics, a company focused on developing a platform to diagnose and prevent complex diseases. In 2003, Willis became a Partner at Ventac Partners, a life science consulting firm involved in strategic consulting and fundraising. From 2016 to 2020, they served as a Business Mentor at Boomtown Accelerator. Additionally, Willis was a member of the Board of Directors at Panion Animal Health AB, which aimed to develop gene therapeutic treatment for epilepsy in dogs. In 2009, they co-founded Boulder Diagnostics Inc., a company dedicated to bringing new diagnostic tests to market. Prior to that, Willis held various leadership roles at miacom diagnostics, Colorado Altitude Training, Proligo LLC, Proligo Biochemie GmbH, and Herberts Refinishes Corp. Overall, they have demonstrated expertise in business leadership, strategic consulting, and biomedical innovation.

Dede Willis has earned a Bachelor of Science degree in Chemical Engineering from Clemson University. Additionally, Dede has pursued further education in the Executive Program for an MBA (Master of Business Administration) from the University of Houston. However, no specific start or end years are provided for either of these educational experiences.